Lumea received a 2025 Global Recognition Award for advancing cancer diagnostics through patented digital pathology software.

Initial imaging suggests malignancy; however, histology shows only inflammation. Follow-up reveals a benign, idiopathic ...

New guidelines confirm that for biomarker testing, navigation‑guided bronchoscopy yields lung tissue equal to that from ...

Using both liquid and tissue biopsies to guide targeted treatment may improve outcomes in patients with solid tumor malignancies.

The human body undergoes a daily replacement of billions of cells, but the tissues remain flawlessly organized. How can that be?

Scientists have uncovered a surprisingly simple “tissue code”: five rules that choreograph when, where, and how cells divide, ...

The global cancer biopsy market is estimated to be valued at USD 35.8 billion in 2025 and is projected to reach USD 195.5 ...

This multicenter study aims to enroll 104 patients over the next 24 months. The primary objective is to evaluate the procedural efficiency of MediView's XR90 Holographic Surgical Navigation system as ...

Although tissue biopsy (TBx) assays remain the diagnostic gold standard because of their ability to directly detect alterations in the tumor, they may not be feasible in patients with inaccessible ...

Second-intention healing may be as good as sutures for 4 mm punch biopsy sites but not for 8 mm sites. Patients with the larger size lesions report more pain and less satisfaction with gel foam.

To evaluate the performance of a circulating tumor DNA (ctDNA) and circulating tumor RNA (ctRNA) liquid biopsy, LiquidHALLMARK (LHM), compared with tissue next-generation sequencing (NGS) and ...